Greenhouse Group will open a 5,040 square foot dispensary located at 1413 W North Ave, Melrose Park, IL 60160, with pre-order available on November 11th and doors to open on November 12th, 2020 . A ribbon cutting ceremony in partnership with the Melrose Park Chamber of Commerce is scheduled for 9:00 a.m. on opening day.

We are thrilled to extend our presence in Illinois with this Melrose Park location, connecting the community to safe and effective cannabis products through our unparalleled expertise,” says Mitch Kahn , CEO. At Greenhouse, we are committed to educating each community we serve on the benefits of cannabis. In addition to providing high-quality and innovative products, we are proud to provide an in-dispensary experience that is inclusive and welcoming to people from all walks of life.”

Located on a main thoroughfare across from Winston Plaza Mall, Greenhouse has a home-grown, welcoming vibe that promotes inclusivity, inviting customers to experience the space as their new home for adult-use cannabis in Illinois .

The open-plan space was deliberately configured to offer a premium, curated customer experience, with a large focus on educational displays throughout the space. The interior will include a consultation zone dedicated to in-depth consultations with trained product specialists, and will have six point of sale stations with social distancing parameters put in place.

The Melrose Park location has filled 33 new jobs, with a focus on inclusive hiring that will drive equitable, diverse growth opportunities within the cannabis industry.

Hours of operation for Greenhouse Melrose Park are Monday-Saturday 9:00 a.m.- 8:00 p.m. and Sunday 10:00 a.m.- 6:00 p.m. Available products will include flower, vapes, extracts/oils, topicals, concentrates, and edibles.

Curaleaf Holdings, Inc. closed on its acquisition of Grassroots on July 23 . In connection with that acquisition, Greenhouse Melrose Park will come under the Curaleaf umbrella and branding pending final regulatory approval.

For more information on Greenhouse, visit the company s website .

High res imagery available HERE

For press inquiries: natalie@skoogco.com

About Greenhouse Group
The Greenhouse Group is committed to building lasting change in their native state of Illinois , serving both medical and recreational customers. It s where passionate product specialists know and serve people from all walks of life, connecting communities to safe, hand-selected, locally-grown products and services. Founded in 2014, Greenhouse operates seven locations: Deerfield , Litchfield , Mokena , Morris , Northbrook , Skokie and their newest addition in Melrose Park, IL. Greenhouse is rooted in raising the standards within cannabis and within the communities they serve. Greenhouse is your home for cannabis . For more information, visit https://www.greenhouseil.com .

About Curaleaf Holdings, Inc.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) (“Curaleaf”) is a leading U.S. provider of consumer products in cannabis, with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a vertically integrated, high-growth cannabis operator known for quality, expertise and reliability, the company and its brands, including Curaleaf and Select provide industry-leading service, product selection and accessibility across the medical and adult-use markets. Curaleaf currently operates in 23 states with 95 dispensaries, 23 cultivation sites and over 30 processing sites, and employs over 3,000 team members across the United States. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information please visit www.curaleaf.com .

Cision View original content to download multimedia: http://www.prnewswire.com/news-releases/greenhouse-to-open-dispensary-in-melrose-park-il-301171769.html

SOURCE Greenhouse

News Provided by PR Newswire via QuoteMedia

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the launch of preclinical research studies using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injuryconcussion (“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.

NAC has been shown to be safe and efficacious in a phase I human clinical study in treating military personnel who had suffered mTBI. The initial research focus is to demonstrate the safety and efficacy of the combination of psilocybin and NAC using broadly accepted rodent models. Final results are expected in 2021. Once this is established, more specific work can examine dose response, medicine uptake, and medicine levels. The research team at the Miller School of Medicine has conducted prior studies involving NAC with mTBI and has a license from the United States Drug Enforcement Administration to conduct research using Schedule I controlled substances, which includes psilocybin.

Keep reading... Show less

Aphria Inc. (” Aphria “, ” we ” or the ” Company “) (TSX: APHA) (NASDAQ: APHA), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, announced it has closed the accretive, strategic acquisition (the ” Acquisition “) of  SW Brewing Company, LLC (” SweetWater Brewing Company ” or ” SweetWater “), one of the largest independent craft brewers in the United States (“U.S.”) based on volume. Beginning with the flagship 420 beverage offerings, SweetWater has created an award-winning lineup of year-round, seasonal and specialty beers, a portfolio of brands closely aligned with a cannabis lifestyle.

Keep reading... Show less
  • Distinguished economist and former CEO of Ecopetrol, Colombia’s largest corporation and the fourth largest Latin America oil and gas producer included in the Fortune Global 500
  • Internationally recognized advocate for the cannabis industry as a driver of change for the Latam economy
  • Adds proven economic and international business experience to boost the global growth of the Khiron business model
  • Company to discuss Q3 2020 financials and host webcast on Tuesday, December 1 st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe announces that Mr. Juan Carlos Echeverry has been appointed to the Board of Directors of the Company, effective immediately. Mr. Echeverry brings extensive corporate, academic and macroeconomic experience, serving as Colombia’s Minister of Finance from 2010 to 2012 and as the CEO and President of Ecopetrol from 2015 to 2017.

Keep reading... Show less

 Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Aurora Cannabis, Inc. (“Aurora” or the “Company”) (NYSE: ACB) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Aurora securities between February 13, 2020, and September 4, 2020, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/acb .

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934.

Keep reading... Show less